Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms
Open Access
- 30 October 2018
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 32 (12) , 2519-2526
Abstract
Tumorigenesis can be considered as pathologically misappropriated tissue regeneration. In this review we will address some unresolved issues that support this concept. First, we will address the issue of the identity of cancer-initiating cells and the presence of cancer stem cells in growing tumors. We will also ask are there rare and distinct populations of cancer stem cells in established tumor cell lines, or are all of the cells cancer stem cells? Second, the most important clinical problem with cancer is its metastasis, and here a challenging question arises: by employing radio-chemotherapy for tumor treatment, do we unintentionally create a prometastatic microenvironment in collateral organs? Specifically, many factors upregulated in response to radio-chemotherapy-induced injury may attract highly migratory cancer cells that survived initial treatment. Third, what is the contribution of normal circulating stem cells to the growing malignancy? Do circulating normal stem cells recognize a tumor as a hypoxia-damaged tissue that needs vascular and stromal support and thereby contribute to tumor expansion? Fourth, is it reasonable to inhibit only one prometastatic ligand–receptor axis when cancer stem cells express several receptors for several chemotactic factors that may compensate for inhibition of the targeted receptor? Fifth, since most aggressive cancer cells mimic early-development stem cells, which properties of embryonic stem cells are retained in cancer cells? Would it be reasonable to inhibit cancer cell signaling pathways involved in the migration and proliferation of embryonic stem cells? We will also briefly address some new players in cancerogenesis, including extracellular microvesicles, bioactive phospholipids, and extracellular nucleotides.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (2R01 DK074720)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL112788)
This publication has 47 references indexed in Scilit:
- Cancer Genome LandscapesScience, 2013
- Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?Leukemia, 2011
- Very Small Embryonic/Epiblast-Like Stem CellsThe American Journal of Pathology, 2009
- Aneuploidy Advantages?Science, 2008
- Cancer Stem CellsNew England Journal of Medicine, 2006
- Gastric Cancer Originating from Bone Marrow-Derived CellsScience, 2004
- Inflammation and cancerNature, 2002
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889
- Congenitales, quergestreiftes Muskelsarkom der NierenVirchows Archiv, 1875